Pharmaceutical giant 'plotted to destroy cancer drugs to drive prices up 4000%'

Leaked internal emails appear to show employees at one of the world’s leading pharmaceutical companies calling for “celebration” over price hikes of cancer drugs, an investigation has revealed.

Staff at Aspen Pharmacare reportedly plotted to destroy stocks of life-saving medicines during a price dispute with the Spanish health service in 2014.

After purchasing five different cancer drugs from British firm GlaxoSmithKline (GSK), the company tried to sell the medicines in Europe for up to 40 times their previous price, reported The Times.

Wearable device could help fight brain cancer

In 2013, the price of one pack of a chemotherapy drug called busulfan, used to treat leukaemia, rose from £5.20 to £65.22 in England and Wales, according to the newspaper.

The other four drugs, including leukeran, also used by leukaemia patients, and melphalan, for skin and ovarian cancers, also became up to four times more expensive.

Price rises for generic cancer drugs, such as those acquired by Aspen, cost the NHS in England around £380m a year for prescriptions dispensed outside hospitals, the European Cancer Congress has estimated.

In a confidential email published by The Times, an Aspen employee appeared to write: “We’ve signed new reimbursement and price agreement successfully: price increases are basically on line with European target prices (Leukeran, a bit higher!)... Let’s celebrate!”

When bargaining over drug prices in Spain, the pharmaceutical giant is said to have threatened to stop selling the cancer treatments unless the Health minister agreed to price rises of up to 4,000 per cent, reported Spanish daily El Confidencial Digital at the time.

Now another leaked email appears to reveal that staff at Aspen discussed destroying their supplies of the drug in the row.

13 ways to help prevent cancer

13 show all 13 ways to help prevent cancer

1/13 Stopping smoking. This notoriously difficult habit to break sees tar build-up in the lungs and DNA alteration and causes 15,558 cancer deaths a year

2/13 Avoiding the sun, and the melanoma that comes with overexposure to harmful UV rays, could help conscientious shade-lovers dodge being one of the 7,220 people who die from it

3/13 A diet that is low in red meat can help to prevent bowel cancer, according to the research - with 30 grams a day recommended for men, and 25 a day recommended for women

4/13 Foods high in fibre, meanwhile, can further make for healthier bowels. Processed foods in developed countries appear to be causing higher rates of colon cancer than diets in continents such as Africa, which have high bean and pulse intakes

5/13 Two servings of fruit and three servings of vegetables a day were given as the magic number for good diet in the research. Overall, diet causes only slightly fewer cancer deaths than sun exposure in Australia, at 7,000 a year

6/13 Obesity and being overweight, linked to poor diet and lack of exercise, causes 3,917 deaths by cancer a year on its own Getty

7/13 Dying of a cancer caused by infection also comes in highly, linked to 3,421 cancer deaths a year. Infections such as human papilloma virus - which can cause cervical cancer in women - and hepatitis - can be prevented by vaccinations and having regular check-ups

8/13 Cutting back on drinks could reduce the risk of cancers caused by alcohol - such as liver cancer, bowel cancer, breast cancer and mouth cancer - that are leading to 3,208 deaths a year 2014 Getty Images

9/13 Sitting around and not getting the heart pumping - less than one hour's exercise a day - is directly leading to about 1,800 people having lower immune functions and higher hormone levels, among other factors, that cause cancers 2011 Getty Images

10/13 Hormone replacement therapy, which is used to relieve symptoms of the menopause in women, caused 539 deaths from (mainly breast) cancer in Australia last year. It did, however, prevent 52 cases of colorectal cancers 2003 Getty Images

11/13 Insufficient breastfeeding, bizarrely, makes the top 10. Breastfeeding for 12 months could prevent 235 cancer cases a year, said the research AFP/Getty Images

12/13 Oral contraceptives, like the Pill, caused about 105 breast cancers and 52 cervical cancers - but it also prevented about 1,440 ovarian and uterine (womb) cases of cancer last year 2006 Getty Images

13/13 Taking aspirin also prevented 232 cases in the Queensland research of colorectal and oesophagal cancers - but as it can also cause strokes, is not yet recommended as a formal treatment against the risk of cancer

The company, which is based in South Africa and has its European headquarters in Dublin, bought the five drugs from GSK in 2009 as part of a deal worth £273m.

The price increases were made possible by a loophole that allows drug companies to change the price of medicines if they are no longer branded with the same name.

The Department of Health has said it plans to cut generic drug costs after researchers said there has been a sharp increase in the price of cancer drugs in the last five years, leading to their use being restricted in the NHS.

The loophole is designed to make drugs cheaper once ther patents have expired – but if drug companies have no competition, they are free to rise prices as well.

It is “worrying” that several drug companies have increased the price of cancer treatment, a senior pharmacology research fellow at the University of Liverpool, told the BBC.

A ruling by the Italian competition watchdog found Aspen had taken an “aggressive” approach to negotiations in the country.

According to The Times’s investigation, the company said it would stop supplying Italy with the drugs in October 2013 if authorities did not agree to price rises of up to 2,100 per cent in three months.

The Independent has contacted Aspen for comment.

A Department of Health spokesperson said new laws were being introduced this year allowing the Government to “take action against excessive price rises on unbranded generic medicines.”

“No pharmaceutical company should exploit the NHS,” they said, reported MailOnline.

“We are working closely with the Competition and Markets Authority on unwarranted price rises of unbranded generic medicines, and where companies have breached competition law, we will seek damages and invest that money in the NHS."